2020-886 Noninvasive Wearable Electroactive Pharmaceutical Monitoring for Personalized Pharmacotherapy

SUMMARY

UCLA researchers in the Department of Electrical and Computer Engineering have developed a non-invasive wearable biosensor for personalized drug monitoring and excretion via sweat.

BACKGROUND

Wearable biosensor technology has become popular in the tracking of heart rate and daily calories. While it also has the potential to be applied for more clinical applications such as tracking drug metabolism in a patient, current voltammetry-based wearables that can detect and quantify metabolites are susceptible to  elimination of electroactive drugs from a patient via sweat. Sweat, which is a complex biofluid matrix, can distort or hide the signal of the target. Therefore, there is a need to develop a wearable voltammetric sensor that can detect the substrate of interest without interference from other compounds within sweat. Such advancements can be used to develop drug monitoring wearables that can be used in a variety of clinically relevant applications, such as drug compliance/abuse as well as personalized therapeutic drug dosing.

INNOVATION

UCLA researchers in the Department of Electrical and Computer Engineering developed a wearable voltammetric sensor that creates an undistorted detection window during which a target drug’s response can be accurately analyzed. The wearable uses a boron-doped diamond sensing interface that prevents contamination of the target signal by complex biofluids such as saliva and sweat. The device is capable of providing a drug readout with a minute-level temporal resolution and has been successfully used to demonstrate the pharmacokinetic correlation and significance of sweat readings. In addition, the device has also been successfully used to demonstrate the first time non-invasive pharmacokinetic monitoring of acetaminophen in a wearable format.

POTENTIAL APPLICATIONS

  • Personalized medicine
  • Pharmacokinetics
  • Drug readout
  • Therapeutic drug monitoring
  • Drug delivery readout

ADVANTAGES

  • Fast readout
  • Wearable sensor
  • Non-invasive
  • Drug recognition in complex matrices

RELATED MATERIALS

STATUS OF DEVELOPMENT

First successful demonstration (first actual reduction to practice)

Patent Information:
For More Information:
Greg Markiewicz
Business Development Officer
greg.markiewicz@tdg.ucla.edu
Inventors:
Sam Emaminejad
Shuyu Lin